Earnings History Data for Astria Therapeutics (ATXS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Astria Therapeutics
Astria Therapeutics is a biopharmaceutical company which focuses on therapies to treat allergic and immunological diseases. The company's program include STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Astria Therapeutics, formerly known as Catabasis Pharmaceuticals Inc., is based in BOSTON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-03-2024 | AH | ATXS | Astria Therapeutics | 630.00 | -0.86 | -0.69 | 0.00 | Astria TherapeuticS GAAP EPS of -$2.42 misses by $0.19 [3/4/2024 4:37 PM] |
13.80 | -0.46 (-3.19%) |
14.23 | -0.03 (-0.21%) |
4.26 - 15.65 | 1,188,953 | 680,000 | 862 | ||
| 13-11-2023 | PM | ATXS | Astria Therapeutics, Inc. | 130.11 | -0.63 | -0.51 | -0.87 | Astria TherapeuticS GAAP EPS of -$0.63 misses by $0.14 [11/13/2023 8:01 AM] |
4.50 | -0.10 (-2.12%) |
0.0 | 0.0 (0.00%) |
4.27 - 16.28 | 145,551 | 290,000 | 0 | ||
| 07-08-2023 | AH | ATXS | Astria Therapeutics | 245.00 | -0.45 | -0.50 | 0.00 | Astria TherapeuticS GAAP EPS of -$0.45 beats by $0.04 [8/7/2023 5:08 PM] |
8.28 | 0.19 (2.35%) |
8.09 | 0.0 (0.00%) |
4.78 - 16.28 | 193,373 | 220,000 | 1,397 | ||
| 22-03-2023 | PM | Before the open (Mar 22) |
ATXS | Astria Therapeutics, Inc. | 360.27 | -0.72 | -0.74 | -0.73 | Astria TherapeuticS GAAP EPS of -$0.72 misses by $0.01 [3/22/2023 8:03 AM] |
11.36 | 0.14 (1.25%) |
0.0 | 0.0 (0.00%) |
2.36 - 16.28 | 190,456 | 340,000 | 0 | |
| 10-11-2021 | PM | Before the open (Nov 10) |
ATXS | Astria Therapeutics, Inc. | 89.13 | -0.61 | -0.74 | -3.36 | Astria TherapeuticS EPS beats by $0.11 [11/10/2021 8:07 AM] |
7.10 | 0.09 (1.28%) |
7.01 | 0.0 (0.00%) |
6.31 - 47.82 | 69,016 | 30,000 | 201 | |
|
||||||||||||||||||